How many studies have been conducted on G M2 Ganglioside?

BiohacksAI has indexed 27 PubMed studies on G M2 Ganglioside, including 1 randomized controlled trials (RCTs). 19% of studies involve human subjects.

What are the main research areas for G M2 Ganglioside?

The primary research domains for G M2 Ganglioside are 🔥 Metabolic, 🫁 Liver & Detox, 🫘 Kidney. This is based on analysis of 27 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

G M2 Ganglioside

A glycosphingolipid that accumulates due to a deficiency of hexosaminidase A or B (BETA-N-ACETYLHEXOSAMINIDASES), or GM2 activator protein, resulting in GANGLIOSIDOSES, heredity metabolic disorders that include TAY-SACHS DISEASE and SANDHOFF DISEASE.

27+ PubMed studies analyzed · 1 RCTs · Evidence Score: 37.8

Research Domains

G M2 Ganglioside has been studied across 10 research domains including 🔥 Metabolic, 🫁 Liver & Detox, 🫘 Kidney, 🧠 Learning, 🧠 Neuroprotection. The primary research focus is 🔥 Metabolic with 30% of studies addressing this area.

Loading evidence profile...

This evidence profile for G M2 Ganglioside is generated deterministically from 27 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.